PFIZER INC.

PFIZER INC. logo
🇺🇸United States
Ownership
Public
Established
1849-01-01
Employees
88K
Market Cap
$163.3B
Website
http://www.pfizer.com

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Phase 4
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Registration Number
NCT00161954
Locations
🇧🇪

SGS Biopharma Research Unit Stuivenberg, Antwerp, Belgium

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Phase 3
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2011-04-26
Lead Sponsor
Pfizer
Target Recruit Count
412
Registration Number
NCT00163111

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-09-13
Last Posted Date
2024-02-21
Lead Sponsor
Pfizer
Target Recruit Count
98
Registration Number
NCT00163189
Locations
🇫🇷

Centre de Perharidy, Roscoff Cedex, France

🇫🇷

Hôpital Lenval, Nice, France

🇫🇷

CHU Timone Enfants, Marseille Cedex 5, France

and more 16 locations

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Phase 2
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Target Recruit Count
615
Registration Number
NCT00161850
Locations
🇦🇹

Grieskirchner Strasse 17, Wels, Austria

🇩🇪

Neuschwanstein Strasse 5, Augsburg, Germany

🇩🇪

Marktplatz 33, Bad Saulgau, Germany

and more 22 locations

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Phase 3
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Target Recruit Count
3800
Registration Number
NCT00161824
Locations
🇵🇱

Zespol Opieki Zdrowotnej w Debicy, Debica, Poland

🇵🇱

Wojewodzki Szpital Dzieciecy Oddzial Obserwacyjno - Zakazny A, Kielce, Poland

🇵🇱

"Atopia" Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego, Krakow, Poland

and more 4 locations

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Phase 2
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Registration Number
NCT00161798
Locations
🇩🇪

Mohrenstrasse 8, Coburg, Germany

🇩🇪

Marktplatz 33, Bad Saulgau, Germany

🇩🇪

Berneckstrasse 19, Schrammberg, Germany

and more 20 locations

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Phase 3
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Target Recruit Count
330
Registration Number
NCT00161928
Locations
🇩🇪

Marktplatz 3, Bad Saulgau, Germany

🇩🇪

Neuschwansteinstrasse 5, Augsburg, Germany

🇦🇹

Grieskirchner Strasse 17, Wels, Austria

and more 11 locations

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Target Recruit Count
321
Registration Number
NCT00161941
Locations
🇩🇪

Löpsinger Strasse 8, Nördlingen, Germany

🇩🇪

Solothurner Strasse 2, Heilbronn, Germany

🇩🇪

Berneckstrasse 19, Schrammberg, Germany

and more 8 locations

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Phase 3
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Target Recruit Count
3973
Registration Number
NCT00161876
Locations
🇵🇱

Zespol Opieki Zdrowotnej w Debicy, Debica, Poland

🇵🇱

PANTAMED sp. z o.o., Olsztyn, Poland

🇵🇱

Przedsiebiorstwo Uslug Medycznych "Centrum Medyczne Nowa Huta", Krakow, Poland

and more 5 locations

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Phase 3
Completed
Conditions
First Posted Date
2005-09-13
Last Posted Date
2015-05-21
Lead Sponsor
Pfizer
Registration Number
NCT00161863
Locations
🇵🇱

Szpital Jana Pawla II Odz. Neuroinfekcji, Krakow, Poland

🇩🇪

Solothurner Strasse 2, Heilbronn, Germany

🇵🇱

PANTAMED sp.z.o.o., Olsztyn, Poland

and more 5 locations
© Copyright 2024. All Rights Reserved by MedPath